Unleashed Informatics has launched SMIDSuite, a small-molecule information suite that contains the Small Molecule Interaction Database (SMID), SMIDBlast, and SMID Genomes. SMID includes protein domain interactions derived from Protein Data Bank 3D structure records and currently contains more than 230,000 domain/small molecule interactions. SMIDBlast runs NCBI's Reverse-PSI BLAST program to match a protein sequence of interest against a library of more than 3,000 domain definitions with more than 5,000 biologically significant small molecules to predict binding sites on the query protein. SMIDGenomes contains more than 12 million predicted small molecule interactions spanning nearly 1,600 complete genomes. Unleashed has also launched UnleashedNEWS, a new feature for its DogBox data warehouse product that delivers news feeds from more than 450 science and technology news feeds.
Movers & Shakers
Mike Story has joined Protein Discovery's scientific advisory board, the company said this week.
Story co-designed the first commercial mass spectrometry system based on quadruple technology and was a co-founder of Finnigan. He is a graduate of UC Berkeley with a BS degree in chemistry and currently is a director of Syagen Technology.
PerkinElmer has named Karl Hecker the new director of R&D for its Boston-based Center of Excellence, the company said this week.
Hecker joins PerkinElmer from Invitrogen and brings over 20 years of scientific experience in chemistry and biochemistry applications. He holds a PhD in biochemistry from Florida State University, a MS in chemistry from Eastern Illinois University, and master's and BS degrees in chemistry from Johann Wolfgang Goethe University, Frankfurt Germany.
Millipore this week announced the appointment of Bruce Bonnevier as corporate vice president of global human resources, and Roland Heinrich as vice president of R&D for the bioprocess division.
Bonnevier previously was vice president of human resources for Hillenbrand Industries, and has served in a similar capacity at Shipley Company, now the electronic materials division of Rohm and Hass. He holds a PhD from the Fielding Institute, an MS from the University of Pennsylvania, and an MA and BA from Pennsylvania State University.
Heinrich most recently was employed as vice president of strategic operations planning for the biopharma and vaccines division of Wyeth. Prior to that, he was a director of manufacturing for protein purification and plant manager at Bayer Corporation. He earned his postdoc at Cambridge University, and a PhD from the University of Arizona.